Press release summary
Parallel Fluidics and Opentrons Labworks have introduced a Flow Processing Unit for the Opentrons Flex liquid-handling platform, bringing microfluidic lipid-nanoparticle formulation onto the robotโs deck.
Lipid nanoparticles are used to deliver mRNA and other genetic medicines. The companies said the combined workflow allows laboratories to move between liquid handling and microfluidic mixing on one programmable platform, with ready-to-run protocols available through the Opentrons Protocol Library.
Parallel Fluidics and Opentrons reported that the system can produce lipid nanoparticles at up to 50 times the throughput of common benchtop instruments. That comparison is company-reported and was not independently evaluated in the announcement. The companies are offering application training and said additional Flow Processing Units for buffer exchange and antibody purification are planned for 2027.
Why it matters to laboratory readers
Combining formulation and routine liquid handling on the same automation platform could help discovery teams run larger design-of-experiments campaigns and create more structured data for statistical or machine-learning analysis. Laboratories will still need to qualify mixing conditions, particle size distribution, encapsulation efficiency, carryover and reproducibility for their specific chemistries. Development teams should also evaluate how results transfer from screening-scale workflows to later process-development and manufacturing systems.
Original source: Parallel Fluidics and Opentrons, Nov. 19, 2026.







Leave a Reply